Profile of omalizumab in the treatment of chronic spontaneous urticaria
Moises Labrador-Horrillo,1 Marta Ferrer2 1Allergy Section, Internal Medicine Department, Vall d’Hebron Hospital, Universitat Autònoma de Barcelona, Barcelona, 2Department of Allergy and Clinical Immunology, Clínica Universidad de Navarra, IDISNA, Instituto de Investi...
Main Authors: | Labrador-Horrillo M, Ferrer M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-08-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/profile-of-omalizumab-in-the-treatment-of-chronic-spontaneous-urticari-peer-reviewed-article-DDDT |
Similar Items
-
Omalizumab in treatment-resistant chronic spontaneous urticaria
by: Kiran V Godse
Published: (2011-01-01) -
Omalizumab for the management of refractory chronic spontaneous urticaria
by: P C Kathuria, et al.
Published: (2022-01-01) -
Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
by: Rabia Kara, et al.
Published: (2022-09-01) -
Omalizumab in chronic spontaneous urticaria: steroid sparing effect
by: Alessia Gatta, et al.
Published: (2018-12-01) -
Omalizumab's efficacy and safety against chronic spontaneous urticaria
by: Öner Özdemir
Published: (2023-08-01)